Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

Fig. 1

Validation of the SARS-CoV-2 RBD specific IgG antibody detection ELISA. The value on the y-axis represents the ratio of OD450 nm to the average mean OD450 nm of the negative controls. The broken black line represents the cut-off value (2.5). We tested a total of 405 serum/plasms samples collected from cohort of mild and moderate (93.6%) and severe Ethiopian COVID-19 patients confirmed by RT-PCR (represented in red color). Of these 325 samples were collected during 0–7 days post-onset of symptoms (dps); 52 were collected during 8–14 dps, and 17 were collected within 15–28 dps (Additional file 1: Table S2). We also tested serum/plasma samples collected from 365 Ethiopian individuals before the global COVID-19 pandemic, represented in blue color (Additional file 1: Table S1)

Back to article page